Heart Foundation’s Smith takes Eli Lilly role

Eli Lilly has appointed British Heart Foundation communications director Maxine Smith as its UK corporate affairs director, following the promotion of Stephen Whitehead earlier this year.

Eli Lilly has appointed British Heart Foundation communications

director Maxine Smith as its UK corporate affairs director, following

the promotion of Stephen Whitehead earlier this year.



She will take up her position in January 2000, reporting to Eli Lilly’s

general manager Derica Rice. Whitehead held the position for 18 months,

before taking up his current position as corporate affairs director for

Europe.



It is not known if Smith will review the company’s agency

relationships.



At the moment Eli Lilly’s agencies include Cohn and Wolfe and Edelman PR

Worldwide, and it recently appointed APCO to handle its public

affairs.



Smith took up her position at the British Heart Foundation, the UK’s

biggest heart charity, in 1995. Prior to this, she worked for the

Cabinet Office, for the Government’s chief scientific adviser. Smith

also has a background in financial and corporate PR, working for

agencies such as Consolidated Communications and Shandwick.



Smith will join at a challenging time for Eli Lilly, whose best-known

product, the anti-depressant Prozac, is due to go off patent in the UK

next year. Sales of the drug have been falling recently, leading to a

drop in the company’s US share price. Prozac has also faced criticism in

the past from the Church of Scientology, and more recently there has

been speculation in the British media that the drug can cause extreme

side-effects in some patients.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.